3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
31
Recurrence
4
Neoplasms, Plasma Cell
3
Lymphoma
2
beta-Thalassemia
1
Thalassemia
1
Sarcoma, Myeloid
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Neoplasms
1
Neoplasm Metastasis
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoglobulin Light-chain Amyloidosis
1
HIV Infections
1
Carcinoma, Non-Small-Cell Lung
1
Anemia, Sickle Cell
1
Interventions
pembrolizumab
1
10-propargyl-10-deazaaminopterin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Subcutaneous panniculitis-like T-cell lymphoma
×
Bortezomib
×
30 days
×
Clear all
No trials found.